Birdwatch Note
2024-08-16 18:12:19 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
In 2020, the Trump Administration established a voluntary, time-limited model. Under this model, participating Medicare Part D prescription drug plans covered at least one of each dosage form and type of insulin product at no more than $35 per month. https://www.kff.org/policy-watch/the-facts-about-the-35-insulin-copay-cap-in-medicare/
Written by C307CCFE9E81A90262D97CDCE741B30638D2433A29CC2A806F3500D1DF376879
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1824498874498576678
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1824509509496344911
- noteId - 1824509509496344911
- participantId -
- noteAuthorParticipantId - C307CCFE9E81A90262D97CDCE741B30638D2433A29CC2A806F3500D1DF376879
- createdAtMillis - 1723831939469
- tweetId - 1824498874498576678
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- In 2020, the Trump Administration established a voluntary, time-limited model. Under this model, participating Medicare Part D prescription drug plans covered at least one of each dosage form and type of insulin product at no more than $35 per month. https://www.kff.org/policy-watch/the-facts-about-the-35-insulin-copay-cap-in-medicare/
Note Ratings
| rated at | rated by | |
| 2024-08-22 16:30:04 -0500 | Rating Details | |
| 2024-08-17 20:04:17 -0500 | Rating Details | |
| 2024-08-17 11:58:32 -0500 | Rating Details | |
| 2024-08-17 11:48:44 -0500 | Rating Details | |
| 2024-08-17 10:04:38 -0500 | Rating Details | |
| 2024-08-17 09:56:30 -0500 | Rating Details | |
| 2024-08-17 09:37:29 -0500 | Rating Details | |
| 2024-08-17 09:36:15 -0500 | Rating Details | |
| 2024-08-17 09:27:40 -0500 | Rating Details | |
| 2024-08-17 08:42:48 -0500 | Rating Details | |
| 2024-08-17 08:39:50 -0500 | Rating Details | |
| 2024-08-17 08:36:44 -0500 | Rating Details | |
| 2024-08-17 08:34:17 -0500 | Rating Details | |
| 2024-08-17 08:25:53 -0500 | Rating Details | |
| 2024-08-17 08:05:15 -0500 | Rating Details | |
| 2024-08-17 07:46:08 -0500 | Rating Details | |
| 2024-08-17 07:44:51 -0500 | Rating Details | |
| 2024-08-17 07:40:28 -0500 | Rating Details | |
| 2024-08-17 07:31:06 -0500 | Rating Details | |
| 2024-08-17 06:36:38 -0500 | Rating Details | |
| 2024-08-17 04:42:01 -0500 | Rating Details | |
| 2024-08-17 02:23:33 -0500 | Rating Details | |
| 2024-08-17 00:05:37 -0500 | Rating Details | |
| 2024-08-16 23:58:34 -0500 | Rating Details | |
| 2024-08-16 23:57:12 -0500 | Rating Details | |
| 2024-08-16 23:11:21 -0500 | Rating Details | |
| 2024-08-16 23:08:02 -0500 | Rating Details | |
| 2024-08-16 20:02:50 -0500 | Rating Details | |
| 2024-08-16 19:47:41 -0500 | Rating Details | |
| 2024-08-16 19:26:12 -0500 | Rating Details | |
| 2024-08-16 19:17:50 -0500 | Rating Details | |
| 2024-08-16 18:58:13 -0500 | Rating Details | |
| 2024-08-16 18:56:36 -0500 | Rating Details | |
| 2024-08-16 18:45:47 -0500 | Rating Details | |
| 2024-08-16 17:56:17 -0500 | Rating Details | |
| 2024-08-16 17:46:40 -0500 | Rating Details | |
| 2024-08-16 17:43:58 -0500 | Rating Details | |
| 2024-08-16 17:36:29 -0500 | Rating Details | |
| 2024-08-16 17:20:35 -0500 | Rating Details | |
| 2024-08-16 17:19:20 -0500 | Rating Details | |
| 2024-08-16 17:17:51 -0500 | Rating Details | |
| 2024-08-16 17:15:43 -0500 | Rating Details | |
| 2024-08-16 17:06:46 -0500 | Rating Details | |
| 2024-08-16 16:48:55 -0500 | Rating Details | |
| 2024-08-16 16:46:32 -0500 | Rating Details | |
| 2024-08-16 16:23:56 -0500 | Rating Details | |
| 2024-08-16 15:43:05 -0500 | Rating Details | |
| 2024-08-16 15:13:10 -0500 | Rating Details | |
| 2024-08-16 15:10:52 -0500 | Rating Details | |
| 2024-08-16 14:50:35 -0500 | Rating Details | |
| 2024-08-16 14:48:22 -0500 | Rating Details | |
| 2024-08-16 14:29:36 -0500 | Rating Details | |
| 2024-08-16 14:26:28 -0500 | Rating Details | |
| 2024-08-16 14:20:33 -0500 | Rating Details | |
| 2024-08-16 14:06:40 -0500 | Rating Details | |
| 2024-08-16 14:01:46 -0500 | Rating Details | |
| 2024-08-16 13:58:20 -0500 | Rating Details | |
| 2024-08-16 13:54:04 -0500 | Rating Details | |
| 2024-08-16 13:47:50 -0500 | Rating Details | |
| 2024-08-16 13:46:43 -0500 | Rating Details | |
| 2024-08-16 13:40:43 -0500 | Rating Details | |
| 2024-08-16 13:39:50 -0500 | Rating Details | |
| 2024-08-16 13:32:52 -0500 | Rating Details | |
| 2024-08-16 13:27:26 -0500 | Rating Details | |
| 2024-08-16 13:22:06 -0500 | Rating Details | |
| 2024-08-16 13:16:12 -0500 | Rating Details | |
| 2024-08-18 12:37:30 -0500 | Rating Details | |
| 2024-08-17 14:33:25 -0500 | Rating Details | |
| 2024-08-17 11:26:42 -0500 | Rating Details | |
| 2024-08-17 11:26:29 -0500 | Rating Details | |
| 2024-08-17 09:41:52 -0500 | Rating Details | |
| 2024-08-17 06:06:16 -0500 | Rating Details | |
| 2024-08-17 03:29:51 -0500 | Rating Details | |
| 2024-08-17 02:25:42 -0500 | Rating Details | |
| 2024-08-16 23:54:53 -0500 | Rating Details | |
| 2024-08-16 22:44:16 -0500 | Rating Details | |
| 2024-08-16 20:34:05 -0500 | Rating Details | |
| 2024-08-16 19:57:10 -0500 | Rating Details | |
| 2024-08-16 19:27:54 -0500 | Rating Details | |
| 2024-08-16 18:12:28 -0500 | Rating Details | |
| 2024-08-16 17:29:52 -0500 | Rating Details | |
| 2024-08-16 17:03:50 -0500 | Rating Details | |
| 2024-08-16 16:58:50 -0500 | Rating Details | |
| 2024-08-16 16:31:54 -0500 | Rating Details | |
| 2024-08-16 15:59:39 -0500 | Rating Details | |
| 2024-08-16 15:57:17 -0500 | Rating Details | |
| 2024-08-16 15:03:00 -0500 | Rating Details | |
| 2024-08-16 14:58:54 -0500 | Rating Details | |
| 2024-08-16 14:33:38 -0500 | Rating Details | |
| 2024-08-16 14:18:03 -0500 | Rating Details | |
| 2024-08-16 13:50:29 -0500 | Rating Details | |
| 2024-08-16 13:44:27 -0500 | Rating Details | |
| 2024-08-16 13:43:03 -0500 | Rating Details | |
| 2024-08-16 13:41:13 -0500 | Rating Details | |
| 2024-08-16 13:27:44 -0500 | Rating Details |